GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Myos Rens Technology Inc (NAS:MYOS) » Definitions » E10

Myos Rens Technology (Myos Rens Technology) E10 : $-20.38 (As of Sep. 2020)


View and export this data going back to 2010. Start your Free Trial

What is Myos Rens Technology E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Myos Rens Technology's adjusted earnings per share data for the three months ended in Sep. 2020 was $-0.840. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-20.38 for the trailing ten years ended in Sep. 2020.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-05), Myos Rens Technology's current stock price is $12.12. Myos Rens Technology's E10 for the quarter that ended in Sep. 2020 was $-20.38. Myos Rens Technology's Shiller PE Ratio of today is .


Myos Rens Technology E10 Historical Data

The historical data trend for Myos Rens Technology's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myos Rens Technology E10 Chart

Myos Rens Technology Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -23.50 - -21.54

Myos Rens Technology Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.40 -21.54 -21.15 -20.64 -20.38

Competitive Comparison of Myos Rens Technology's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Myos Rens Technology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Myos Rens Technology's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Myos Rens Technology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Myos Rens Technology's Shiller PE Ratio falls into.



Myos Rens Technology E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Myos Rens Technology's adjusted earnings per share data for the three months ended in Sep. 2020 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2020 (Change)*Current CPI (Sep. 2020)
=-0.84/109.8149*109.8149
=-0.840

Current CPI (Sep. 2020) = 109.8149.

Myos Rens Technology Quarterly Data

per share eps CPI Adj_EPS
201012 0.000 92.474 0.000
201103 -24.000 94.283 -27.954
201106 -24.000 95.235 -27.674
201109 18.000 95.727 20.649
201112 -18.000 95.213 -20.760
201203 -6.000 96.783 -6.808
201206 -12.000 96.819 -13.611
201209 -6.000 97.633 -6.749
201212 -7.560 96.871 -8.570
201303 -5.640 98.209 -6.306
201306 -5.280 98.518 -5.885
201309 -4.200 98.790 -4.669
201312 -7.680 98.326 -8.577
201403 -1.920 99.695 -2.115
201406 -4.080 100.560 -4.456
201409 -9.000 100.428 -9.841
201412 -3.360 99.070 -3.724
201503 -6.000 99.621 -6.614
201506 -4.440 100.684 -4.843
201509 -4.680 100.392 -5.119
201512 -4.680 99.792 -5.150
201603 -3.720 100.470 -4.066
201606 -3.600 101.688 -3.888
201609 -2.040 101.861 -2.199
201612 -1.680 101.863 -1.811
201703 -2.400 102.862 -2.562
201706 -2.280 103.349 -2.423
201709 -1.560 104.136 -1.645
201712 -2.040 104.011 -2.154
201803 -2.280 105.290 -2.378
201806 -1.680 106.317 -1.735
201809 -1.440 106.507 -1.485
201812 0.000 105.998 0.000
201903 -1.560 107.251 -1.597
201906 -1.560 108.070 -1.585
201909 -1.200 108.329 -1.216
201912 -1.320 108.420 -1.337
202003 -1.080 108.902 -1.089
202006 -0.840 108.767 -0.848
202009 -0.840 109.815 -0.840

Add all the adjusted EPS together and divide 10 will get our e10.


Myos Rens Technology  (NAS:MYOS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Myos Rens Technology E10 Related Terms

Thank you for viewing the detailed overview of Myos Rens Technology's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Myos Rens Technology (Myos Rens Technology) Business Description

Traded in Other Exchanges
N/A
Address
45 Horsehill Road, Suite 106, Cedar Knolls, NJ, USA, 07927
Myos Rens Technology Inc is a US-based bio-nutrition and biotherapeutics company. It focuses on the discovery, development, and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. The company develops nutritional and therapeutic products for maintaining and improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases such as Sarcopenia, Cachexia, and others.
Executives
Joseph Mannello director, officer: Chief Executive Officer C/O BREAN CAPITAL, LLC, 1345 AVENUE OF THE AMERICAS, 29TH FLOOR, NEW YORK NY 10105
Victor E Mandel director PO BOX 5962, WASHINGTON DC 20016
Robert J Hariri director 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Christopher Pechock director C/O MATLINPATTERSON GLOBAL ADVISORS INC, 520 MADISON AVE, NEW YORK NY 10022-4213
Christopher C Dewey director 120 BROADWAY, 27TH FLOOR, NEW YORK NY 10271
Louis J. Aronne director 4640 ADMIRALTY, SUITE 500, MARINA DEL RAY CA 90292
Eric Zaltas director 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ 07927
Andrew Joel Ponte director 45 HORSEHILL ROAD, SUITE 106, CEDAR KNOLLS NJ 07927
David J Matlin 10 percent owner
John Nosta director 45 HORSEHILL ROAD, SUITE 106, CEDAR KNOLLS NJ 07927
Zhengguang Lyu director 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019
Ren Ren director, 10 percent owner 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019
Rens Technology Inc 10 percent owner 150 DRAKE STREET ROOM 7F, POMONA CA 91767
Rens Agriculture Science & Technology Co, Ltd 10 percent owner 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019
Guiying Zhao director 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019

Myos Rens Technology (Myos Rens Technology) Headlines

From GuruFocus

MYOS CEO Joseph Mannello Issues Letter to Shareholders

By PRNewswire PRNewswire 01-09-2020